Pennington Biomedical Research Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Pennington Biomedical Research Center sits in the top decile of US sponsors by registered trial count (#128 of 15,742 sponsors by registered trial count).
Pennington Biomedical Research Center: 258 sponsored US clinical trials, 33 recruiting.
Pennington Biomedical Research Center sponsors 258 registered US clinical trials on ClinicalTrials.gov, 33 of them currently recruiting, and 193 completed. 12 of these trials are in Phase 3-4 (later-stage) and 20 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
Pennington Biomedical Research Center ranks in the top decile of sponsors by registered trial count (#128 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
193 of 209 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
258 total, page 5 of 6
Postpartum Weight Loss and Exercise (PRIDE)
NCT01296516
Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women
NCT01748994
International Study of Childhood Obesity, Lifestyle and the Environment
NCT01722500
The Comparison of Energy in Take and Body Weight EXERCISE
NCT01264406
Effect of Exercise-Induced Weight Loss on Energy Metabolism
NCT01775163
Stimulation of Diet-Induced Thermogenesis by Cold-Exposure
NCT01898949
Palatability (Energy I Pilot)
NCT01653886
Bariatric Surgery and Weight Loss on Energy Metabolism and Insulin Sensitivity
NCT00936130
Which is a Better Breakfast? Egg or Cereal?
NCT01413217
Positive Energy I Through Overfeeding
NCT01653145
Oscillations of Dietary Fat/Carbohydrate Intake Over Interval of 3 to 4 Days
NCT01115075
Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population
NCT01264757
Anthropometric Assessment of Abdominal Obesity and Health Risk in Children and Adolescents
NCT01595100
Weight Loss in Chronic Disease Patient Population
NCT01155050
Effect of Dietary Fat When Eaten With Fructose Versus Glucose
NCT01061346
Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell
NCT01021176
Effect of Cinnamon Extract on Insulin Resistance in Polycystic Ovary Syndrome
NCT00970541
The Insulin Sensitivity Using Aerobic Interval Conditioning
NCT01286922
Cancer Survival Through Weight Loss and Exercise
NCT01217216
Evaluation of the Remote Intervention for Diet and Exercise (RIDE)
NCT00883350
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
NCT02135965
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
NCT01148563
Geranium Oil and Its Components for the Relief of Numbness-OB 100
NCT01022437
EPT 100: Geranium Oil for the Relief of Neuropathic Pain
NCT01007747
Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate
NCT00999297
Fat Cell Size and Overfeeding and Etopic Study
NCT01672632
Horton & Maizy Pilot Study for Resistant to Starch
NCT01338571
Effect of Fenugreek on Blood Sugar and Insulin in Diabetic Humans
NCT00597350
Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
NCT00624416
"ISIS" Study of Sex Differences in Characteristics of Adiposity and Metabolism
NCT00704197
Sedentary Behavior in African Americans
NCT00907465
CALERIE Phase II Ancillary: Metabolic
NCT02695511
Assessment of Energy Balance
NCT01678885
Mechanisms of the Effect of Physical Activity on the Adaptation to a High-Fat Diet
NCT00611117
Standardized Eucommia Extract in the Treatment of Hypertension
NCT00626132
Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes
NCT00458133
Replace Glycemic Load and Satiety Study
NCT01516333
Effects of Exercise for Overweight Women With Polycystic Ovary Syndrome
NCT01150539
"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM
NCT00402012
ACTIV- Exercise Intervention in Healthy Young Men
NCT00401791
Safety and Efficacy Study of Tarragon on Insulin Action in Humans
NCT01057576
Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation
NCT00287053
Effects of Stevia on Satiety and Eating Attitudes in Healthy, Overweight and Obese Adults
NCT01115088
The Louisiana (LA) Health Project
NCT00289315
LOSS- Louisiana Obese Subjects Study
NCT00115063
The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet
NCT00138645
Effects of Chromium Picolinate on Food Intake
NCT00477854
PROOF: PROtein OverFeeding Effect on Body Weight
NCT00565149
Efficacy of Olibra: A 12 Week Controlled Trial
NCT01416051
Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes
NCT00398853
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Pennington Biomedical Research Center pipeline
33 recruiting of 258 indexed (13% open); 193 completed (75%).
Phase mix: 12 late (III/IV) vs 20 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Pennington Biomedical Research Center: open-pipeline peers nationwide
Peers matched on 258 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Pennington Biomedical Research Center sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 258 trials (± recruiting share)
- University of Texas at Austin · 257 trials · 23% recruiting
- Abbott Medical Devices · 261 trials · 9% recruiting
- Boston Medical Center · 253 trials · 11% recruiting
- University of South Florida · 252 trials · 17% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Temple University · 13% recruiting · 163 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- University of Pittsburgh · 13% recruiting · 1,238 trials
Related
What to do with this Pennington Biomedical Research Center page
258 registered trials is a research-attention snapshot, not an endorsement of Pennington Biomedical Research Center or any single study.
- 33 of Pennington Biomedical Research Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Pennington Biomedical Research Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Pennington Biomedical Research Center pipeline card: 258 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.